Skip to content

Clinical trials

Withdrawn Ovarian Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Status: Withdrawn Clear all

111 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20032
20053
20066
20071
20085
20095
20103
20114
20125
20145
20153
20169
20173
20185
20194
20202
20218
20226
20239
20247
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn111

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gynecologic Oncology Group8
M.D. Anderson Cancer Center5
University of Alabama at Birmingham5
National Cancer Institute (NCI)4
AstraZeneca3
City of Hope Medical Center3
OHSU Knight Cancer Institute3
Roswell Park Cancer Institute3
Dana-Farber Cancer Institute2
Haider Mahdi2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms111
Fallopian Tube Neoplasms25
Breast Neoplasms18
Carcinoma, Ovarian Epithelial16
Carcinoma, Non-Small-Cell Lung9
Endometrial Neoplasms9
Pancreatic Neoplasms9
Triple Negative Breast Neoplasms8
Uterine Cervical Neoplasms8
Lung Neoplasms7

Trials

Showing 51 to 75 of 111. Each trial links to its page on Pharma Observatory.

11 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.